We identified a stronger loss of CXCR3+ and CXCR6+ CD8+ T cells and overall stronger activation of NK cells and T cells in the blood of influenza patients as compared to COVID-19 patients, in line with the recent observation of a lower inflammatory profile in COVID-19 patients as compared to influenza patients (15). The gene discussed is CXCR6; the disease is COVID-19.